Altheadx, inc. appoints industry veteran derek maetzold to its board of directors

San diego, may 26, 2021   /prnewswire/ -- altheadx, a commercial stage, precision medicine company with the world's leading pharmacogenomics test for anxiety and depression announced today that it has appointed derek maetzold to its board of directors. mr. maetzold is altheadx's fourth director and brings not only strong knowledge of the diagnostics industry, but also operations and management experience.
CSTL Ratings Summary
CSTL Quant Ranking